Shiyan Wang

2.8k total citations
42 papers, 1.8k citations indexed

About

Shiyan Wang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shiyan Wang has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Shiyan Wang's work include RNA modifications and cancer (11 papers), Cancer-related gene regulation (9 papers) and Cancer-related molecular mechanisms research (7 papers). Shiyan Wang is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related gene regulation (9 papers) and Cancer-related molecular mechanisms research (7 papers). Shiyan Wang collaborates with scholars based in China, Hong Kong and Canada. Shiyan Wang's co-authors include Jun Yu, Joseph J.�Y. Sung, Wei Kang, Xueji Zhang, Housheng Hansen He, Haifeng Dong, Huiting Lu, Huangxian Ju, Ka‐Fai To and Jianning Zhai and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and Gastroenterology.

In The Last Decade

Shiyan Wang

38 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiyan Wang China 20 1.4k 633 240 183 134 42 1.8k
Ganfeng Xie China 22 849 0.6× 576 0.9× 297 1.2× 277 1.5× 209 1.6× 44 1.6k
Xiaoli Zhu China 22 948 0.7× 689 1.1× 208 0.9× 140 0.8× 109 0.8× 57 1.6k
Frances L. Byrne Australia 22 1.2k 0.9× 603 1.0× 166 0.7× 117 0.6× 57 0.4× 53 1.9k
Yanan Chen China 21 1.0k 0.7× 314 0.5× 392 1.6× 153 0.8× 81 0.6× 68 1.6k
Dong Xu China 20 1.1k 0.8× 637 1.0× 257 1.1× 394 2.2× 116 0.9× 53 1.8k
Johannes Winkler Austria 24 1.5k 1.1× 453 0.7× 142 0.6× 152 0.8× 81 0.6× 78 2.3k
Hongmei Zheng China 21 712 0.5× 435 0.7× 261 1.1× 163 0.9× 69 0.5× 67 1.2k
Chen Wu China 19 1.0k 0.7× 641 1.0× 160 0.7× 141 0.8× 144 1.1× 78 1.5k
Yun‐Hee Kim South Korea 21 820 0.6× 473 0.7× 357 1.5× 120 0.7× 52 0.4× 70 1.5k
Zhenyu Ji China 18 851 0.6× 600 0.9× 185 0.8× 237 1.3× 85 0.6× 58 1.4k

Countries citing papers authored by Shiyan Wang

Since Specialization
Citations

This map shows the geographic impact of Shiyan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyan Wang more than expected).

Fields of papers citing papers by Shiyan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiyan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyan Wang. The network helps show where Shiyan Wang may publish in the future.

Co-authorship network of co-authors of Shiyan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shiyan Wang. A scholar is included among the top collaborators of Shiyan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiyan Wang. Shiyan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Heming, Huarong Chen, Weixin Liu, et al.. (2025). Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer. Nature Communications. 17(1). 803–803.
2.
Su, Tianhong, Shiyan Wang, Xiaoxing Li, et al.. (2024). N6 -Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression. Cancer Research. 84(6). 827–840. 50 indexed citations
3.
Xie, Tong, Weijie Zhu, Cui Zhang, et al.. (2024). Single-cell transcriptomics reveals tumor microenvironment changes and prognostic gene signatures in hepatocellular carcinoma. International Immunopharmacology. 143(Pt 2). 113317–113317. 2 indexed citations
4.
Qin, Shugang, Shiyan Wang, Min Sun, et al.. (2023). Herbal Medicine Nanocrystals: A Potential Novel Therapeutic Strategy. Molecules. 28(17). 6370–6370. 19 indexed citations
5.
Zhai, Jianning, Huarong Chen, Chi Chun Wong, et al.. (2023). ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy. Gastroenterology. 165(2). 445–462. 88 indexed citations
7.
Wang, Jing, et al.. (2023). Identification immune response genes in psoriasis after treatment with secukinumab. BMC Medical Genomics. 16(1). 77–77. 4 indexed citations
9.
Tang, Xiaojuan, Qing Tang, Shiyan Wang, et al.. (2022). Curcumol repressed cell proliferation and angiogenesis via SP1/mir-125b-5p/VEGFA axis in non-small cell lung cancer. Frontiers in Pharmacology. 13. 1044115–1044115. 16 indexed citations
10.
Chen, Huarong, Shanshan Gao, Weixin Liu, et al.. (2020). RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target. Gastroenterology. 160(4). 1284–1300.e16. 231 indexed citations
11.
Chen, Jiahuan, Xiaodong Liang, Shasha Zhang, et al.. (2020). Two faces of bivalent domain regulate VEGFA responsiveness and angiogenesis. Cell Death and Disease. 11(1). 75–75. 9 indexed citations
12.
Wang, Shiyan, Junzhe Huang, Chuangen Li, et al.. (2019). MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer. Clinical Cancer Research. 26(3). 746–757. 8 indexed citations
13.
Wang, Shiyan, Yanquan Zhang, Junzhe Huang, et al.. (2019). TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression. Cancer Research. 79(16). 4086–4098. 76 indexed citations
14.
Zeng, Yong, Shiyan Wang, Shanshan Gao, et al.. (2018). Refined RIP-seq protocol for epitranscriptome analysis with low input materials. PLoS Biology. 16(9). e2006092–e2006092. 104 indexed citations
15.
16.
Kang, Wei, Joanna H. Tong, Anthony W.H. Chan, et al.. (2014). Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma. Journal of Translational Medicine. 12(1). 80–80. 57 indexed citations
17.
Wang, Yu, Feifeng Ren, Yue Feng, et al.. (2013). CHIP/Stub1 functions as a tumor suppressor and represses NF- B-mediated signaling in colorectal cancer. Carcinogenesis. 35(5). 983–991. 79 indexed citations
18.
Yu, Jun, Bo Shen, Eagle S.H. Chu, et al.. (2010). Inhibitory Role of Peroxisome Proliferator-Activated Receptor Gamma in Hepatocarcinogenesis in Mice and in Vitro. Hepatology. 51(6). 2008–2019. 102 indexed citations
19.
Yu, Jun, Zhirong Zeng, Shiyan Wang, et al.. (2009). IL-1B -511 Polymorphism Is Associated With Increased Risk of Certain Subtypes of Gastric Cancer in Chinese: A Case–Control Study. The American Journal of Gastroenterology. 105(3). 557–564. 18 indexed citations
20.
Yu, Jun, Eagle S.H. Chu, Ruizhi Wang, et al.. (2009). Heme Oxygenase-1 Protects Against Steatohepatitis in Both Cultured Hepatocytes and Mice. Gastroenterology. 138(2). 694–704.e1. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026